The FDA encourages stakeholders to engage with the Nanotechnology Task Force through various channels. Industry representatives, researchers, and the public can participate in public meetings, submit comments on draft guidelines, and collaborate on research initiatives. This inclusive approach helps the task force stay informed about emerging trends and stakeholder concerns.
